This segment focuses on the research, development, manufacturing, and commercialization of recombinant human growth hormone (rhGH) products, primarily under the Ansomone brand. R&D activities include optimizing rhGH formulations and delivery methods to improve efficacy and patient convenience. The company utilizes advanced biotechnology and cell culture techniques to produce high-quality rhGH. The therapeutic area is growth hormone deficiency in both children and adults. Patient impact includes improved growth, metabolism, and overall quality of life. Anhui Anke Biotechnology holds a strong market position in China, with a focus on expanding its rhGH product line and exploring new applications. Future opportunities include developing long-acting rhGH formulations and expanding into international markets. Regulatory aspects involve adherence to stringent GMP standards and clinical trials to demonstrate safety and efficacy. The company has partnerships with various research institutions to enhance its research capabilities.

This segment concentrates on the development, production, and marketing of recombinant human interferon alpha 2b products, including lyophilized powder, liquid, prefilled syringes, creams, eye drops, and suppositories, under the Anterferon brand. Research and development efforts are focused on improving the stability, efficacy, and delivery of interferon alpha 2b. The company employs advanced protein engineering and formulation technologies. The therapeutic applications include the treatment of viral infections and certain cancers. The patient impact involves improved immune response and disease management. Anhui Anke Biotechnology aims to maintain its market share in China and explore new indications for interferon alpha 2b. Future opportunities include developing novel interferon formulations and combination therapies. Regulatory compliance is crucial, requiring rigorous clinical trials and adherence to regulatory guidelines. The company collaborates with research institutions to enhance its understanding of interferon's therapeutic potential.

This segment involves the development, manufacturing, and sales of various diagnostic kits, including those for anti-sperm antibody detection, semen analysis, sperm DNA fragmentation, and leptin and immunohistochemical assays. R&D activities focus on improving the sensitivity, specificity, and ease of use of diagnostic tests. The company utilizes advanced immunoassay and molecular biology techniques. The therapeutic areas include reproductive health, fertility, and tumor diagnostics. Patient impact includes improved diagnosis and treatment of related conditions. Anhui Anke Biotechnology aims to expand its diagnostic product portfolio and enhance its market presence in China. Future opportunities include developing new diagnostic tests for emerging diseases and personalized medicine applications. Regulatory compliance is essential, requiring adherence to quality control standards and clinical validation. The company collaborates with medical institutions and research centers to improve its diagnostic capabilities.

This segment encompasses the development, manufacturing, and commercialization of a wide range of pharmaceutical products, including adhesive plasters, oral solutions, topical preparations, ointments, peptide APIs, beauty care and anti-aging products, and synthetic drugs in various forms. R&D activities include drug discovery, formulation development, and process optimization. The company utilizes advanced pharmaceutical manufacturing technologies and quality control systems. The therapeutic areas covered are diverse, including pain management, dermatology, and general health. Patient impact includes improved treatment options and enhanced quality of life. Anhui Anke Biotechnology aims to expand its product portfolio and strengthen its market position in China and internationally. Future opportunities include developing innovative drug delivery systems and expanding into new therapeutic areas. Regulatory compliance is critical, requiring adherence to GMP standards and clinical trials. The company collaborates with research institutions and pharmaceutical companies to enhance its product development capabilities.